← Back to patent-cliff list
Seal oil omega-3 polyunsaturated fatty acid
Tier C — Watch / tradeSeal oil omega-3 polyunsaturated fatty acid
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：PPARα, CYP2E1
Indications (approved)：Inflammatory disease, 脂肪肝
Regional status
US
Phase III
2018-01-01
EU
-
China
Discontinued
2011-10-21
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Seal oil omega-3 polyunsaturated fatty acid?
Approved indications include: Inflammatory disease, 脂肪肝.
When does the Seal oil omega-3 polyunsaturated fatty acid patent expire?
No public expiry year is available for Seal oil omega-3 polyunsaturated fatty acid yet; this page updates once verified.
How do I get a quote for Seal oil omega-3 polyunsaturated fatty acid intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-09